SAN DIEGO, Jan. 18, 2017 -- Square 1 Bank, a division of Pacific Western Bank, today announced that it has provided a $5 million credit facility to new client Argonaut Manufacturing Services, a leading contract manufacturer for biotech companies. Proceeds from the facility will support capital expenditures associated with the company’s recent expansion.
Headquartered in Carlsbad, CA, Argonaut provides contract manufacturing for top suppliers of molecular diagnostic and life science reagents and consumables. The company’s experienced team supports all product stages, from launch to revitalization, with services such as project planning, supplier management and global logistics. Clients benefit by receiving products compliant with applicable regulations and savings realized through cost variabilization.
“With business expanding and the opportunity to offer more services to our clients, Square 1 was our top choice for support,” stated Wayne Woodard, chief executive officer of Argonaut MS. “Square 1 definitely demonstrated their experience in helping life sciences entrepreneurs. They took the time to understand our business and long-term strategy, and then delivered exactly what we needed.”
“Argonaut’s leadership team has more than 100 years of operational experience, so they are well equipped to address most any supply chain challenge,” added Rilus Graham, senior vice president in Square 1’s life sciences practice. “With venture backing from Telegraph Hill Partners and the additional support of this credit facility, Argonaut is poised for growth. Square 1 is excited to support the company in its mission to accelerate innovation and unlock hidden potential in life science supply chains.”
About Square 1 Bank
Square 1 Bank is a division of Pacific Western Bank, a Los Angeles-based commercial bank with over $21 billion in assets. A full service financial services partner to entrepreneurs and their investors, Square 1 provides clients flexible resources and attentive service to help their companies grow. Square 1 offers a broad range of venture debt, treasury and cash management solutions through offices in top innovation centers: Atlanta, Austin, the Bay Area, Boston, Chicago, Denver, Durham, Los Angeles, Minneapolis, New York, San Diego, Seattle and Washington, DC. Pacific Western Bank is a wholly-owned subsidiary of PacWest Bancorp (NASDAQ:PACW). For more information, visit www.square1bank.com.
About Argonaut Manufacturing Services
Argonaut MS provides contract manufacturing in the life science and biotech arena for clients looking to leverage their supply chain. With experience supporting product launch, scale-up and revitalization, Argonaut MS houses over 7500 sq.ft. of clean room production area and 3000 sq. ft. of “research use only” manufacturing space at their headquarters in Carlsbad, CA. Argonaut MS is backed by the venture capital team, Telegraph Hill Partners. For more information, visit www.argonautms.com
Media Contact: Square 1 Bank, a division of Pacific Western Bank Dee McDougal 919.597.7479 [email protected]


Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Italy Fines Apple €98.6 Million Over App Store Dominance 



